NDC product
Motion Sickness
NDC 11673-198 · Target Corporation
Key facts
| Product NDC | 11673-198 |
|---|---|
| Proprietary name | Motion Sickness |
| Nonproprietary name | Dimenhydrinate |
| Substances | DIMENHYDRINATE |
| Dosage form | TABLET |
| Route | ORAL |
| Labeler | Target Corporation |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M009 |
| Pharmacologic classes | Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC] |
| Marketing start | Dec 1, 1992 |
| Marketing end | Oct 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory